217 related articles for article (PubMed ID: 8208774)
1. Acute sensitization to opioid antagonists.
White-Gbadebo D; Holtzman SG
Pharmacol Biochem Behav; 1994 Mar; 47(3):559-66. PubMed ID: 8208774
[TBL] [Abstract][Full Text] [Related]
2. Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
White-Gbadebo D; Holtzman S
Psychopharmacology (Berl); 1994 Mar; 114(2):225-8. PubMed ID: 7838911
[TBL] [Abstract][Full Text] [Related]
3. Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.
Easterling KW; Holtzman SG
J Pharmacol Exp Ther; 1997 Apr; 281(1):188-99. PubMed ID: 9103497
[TBL] [Abstract][Full Text] [Related]
4. In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation.
Easterling KW; Holtzman SG
Psychopharmacology (Berl); 2004 Sep; 175(3):287-95. PubMed ID: 15024547
[TBL] [Abstract][Full Text] [Related]
5. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
[TBL] [Abstract][Full Text] [Related]
6. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Morgan D; Picker MJ
Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
[TBL] [Abstract][Full Text] [Related]
7. Blocking of enhanced sensitivity to behavioral effects of naloxone induced by narcotic agonists in rats.
Jain R; Ray R
Indian J Physiol Pharmacol; 2003 Oct; 47(4):407-14. PubMed ID: 15266952
[TBL] [Abstract][Full Text] [Related]
8. Limitations on the antagonistic actions of opioid antagonists.
Young AM; Woods JH
Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.
France CP; Woods JH
J Pharmacol Exp Ther; 1985 Nov; 235(2):442-7. PubMed ID: 4057080
[TBL] [Abstract][Full Text] [Related]
10. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
[TBL] [Abstract][Full Text] [Related]
11. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
Harris RA
J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
Adams JU; Holtzman SG
J Pharmacol Exp Ther; 1990 May; 253(2):483-9. PubMed ID: 2338644
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
[TBL] [Abstract][Full Text] [Related]
16. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
Walker EA; Sterious SN
Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
18. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
[TBL] [Abstract][Full Text] [Related]
19. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
20. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
